InvestorsHub Logo
Followers 74
Posts 15845
Boards Moderated 0
Alias Born 04/26/2010

Re: Nukemtiltheyglow post# 26659

Thursday, 04/17/2014 3:01:00 PM

Thursday, April 17, 2014 3:01:00 PM

Post# of 426444
What risks are Kowa taking? Seems to me not many - copromotion doesn't mean they have to higher more sales reps, they're already out there selling Livalo, which is going generic, as is their other product, Lipofen, a fenofibrate - the patent for Lipofen is due to expire on January 10, 2015. Seems to me both companies need each other to survive! Makes for a perfect pairing.

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News